Park Square Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.77K Sell
76
-18
-19% -$2.11K 0.09% 78
2026
Q1
$11.2K Sell
94
-37
-28% -$4.27K 0.08% 79
2025
Q4
$12.9K Buy
131
+129
+6,450% +$12.1K 0.08% 127
2025
Q3
$84 Sell
2
-2,437
-100% -$201K ﹤0.01% 254
2025
Q2
$193K Sell
2,439
-125
-5% -$9.94K 0.14% 111
2025
Q1
$230K Sell
2,564
-1,185
-32% -$111K 0.18% 76
2024
Q4
$373K Buy
+3,749
New +$387K 0.26% 51

Other funds holding MRK

Park Square Financial Group's MRK Position: Q2 2026 in Review

Park Square Financial Group reduced its Merck (MRK) stake by 19% in Q2 2026, selling an estimated $2.11K and leaving 76 shares worth $9.77K. The position accounts for 0.09% of the portfolio, ranked #78.

Park Square Financial Group first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $373K in Q4 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Park Square Financial Group held 76 shares of Merck worth $9.77K as of Q2 2026.
  • Park Square Financial Group sold 18 Merck shares in Q2 2026, an estimated $2.11K.
  • Merck made up 0.09% of Park Square Financial Group's portfolio in Q2 2026, its #78 holding.
  • Park Square Financial Group first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Park Square Financial Group's Merck position peaked at $373K in Q4 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Park Square Financial Group's 13F filing for Q2 2026, filed 31 Jul 2026.